| RS2503174606 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2503175759 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503179006 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, Ovarian cancer |
| RS2503180084 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503180145 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503180293 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2503180387 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503180411 |
SPTB
|
Health Risk |
Pathogenic |
SPTB-related disorder, SPTB-related disorder |
| RS2503180903 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503181299 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503181309 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503181366 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503183916 |
FANCM
|
Health Risk |
Pathogenic |
— |
| RS2503185723 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503185754 |
POMT2
|
Health Risk |
Likely pathogenic |
— |
| RS2503187799 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503188605 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2503188648 |
FANCM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503193129 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503193443 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2503194551 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS2503194575 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS2503195017 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503195040 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS2503196861 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503196938 |
CHAMP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 40 |
| RS2503197133 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2503197148 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2503197798 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503198124 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503198171 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503198180 |
CHAMP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 40 |
| RS2503198272 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503198347 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503198577 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503198675 |
SPTB
|
Health Risk |
Likely pathogenic |
SPTB-related disorder, SPTB-related disorder |
| RS2503199240 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503201849 |
CHAMP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 40 |
| RS2503203091 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2503203454 |
CHAMP1
|
Health Risk |
Pathogenic |
— |
| RS2503203617 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503203792 |
POMT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2503203938 |
CHAMP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 40 |
| RS2503203991 |
CHAMP1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2503204104 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503204284 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503204380 |
CHAMP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 40 |
| RS2503204393 |
CHAMP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 40 |
| RS2503204562 |
CHAMP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 40 |
| RS2503204756 |
CHAMP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 40 |
| RS2503205188 |
IFT43
|
Health Risk |
Pathogenic |
— |
| RS2503207877 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503210409 |
SPTB
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503211315 |
MLH3
|
Health Risk |
Likely pathogenic |
— |
| RS2503213341 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503213372 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503213449 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503213538 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503213570 |
SPTB
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503216999 |
VIPAS39
|
Health Risk |
Pathogenic |
— |
| RS2503219644 |
SPTB
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503219666 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503219921 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503219999 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503220370 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503220523 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2503222098 |
FANCM
|
Health Risk |
Likely pathogenic |
— |
| RS2503222671 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS2503226690 |
POMT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2503226705 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503226970 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503227003 |
POMT2
|
Health Risk |
Pathogenic |
— |
| RS2503227032 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2503227296 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2503227366 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503227404 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503227561 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503238068 |
FANCM
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503244893 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503246700 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503247331 |
FANCM
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503248407 |
SMOC1
|
Health Risk |
Pathogenic |
— |
| RS2503260477 |
MLH3
|
Health Risk |
Likely pathogenic |
Endometrial carcinoma, Endometrial carcinoma |
| RS2503266718 |
NEMF
|
Health Risk |
Likely pathogenic |
NEMF-related disorder, NEMF-related disorder |
| RS2503266791 |
NEMF
|
Health Risk |
Pathogenic |
— |
| RS2503267774 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2503268787 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS2503270978 |
NEMF
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay and axonal peripheral neuropathy, Intellectual developmental disorder with speech delay and axonal peripheral neuropathy |
| RS2503271370 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503271575 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503276780 |
POMT2
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy |
| RS2503278063 |
SOX5
|
Health Risk |
Likely pathogenic |
Lamb-Shaffer syndrome, Lamb-Shaffer syndrome |
| RS2503278888 |
TTLL5
|
Health Risk |
Pathogenic |
— |
| RS2503279758 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503280177 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503280308 |
SMOC1
|
Health Risk |
Pathogenic |
— |
| RS2503280642 |
SOX5
|
Health Risk |
Pathogenic |
— |
| RS2503280908 |
FANCM
|
Health Risk |
Likely pathogenic |
— |
| RS2503285522 |
POMT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS2503285557 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |